US Bill Targets $35 Monthly Insulin Cost Cap Nationwide

A bipartisan group of U.S. lawmakers has introduced a new bill aimed at reducing the financial burden of insulin for millions of Americans living with diabetes. The proposed INSULIN Act seeks to cap out-of-pocket insulin costs at $35 per month for individuals with private health insurance.

The move comes as families across the country continue to struggle with the high cost of this life-saving medication. For example, a two-year-old child in Mississippi with Type 1 diabetes recently required insulin supplies costing nearly $200 in a single month—even with insurance coverage. While the family is managing for now, concerns about long-term affordability remain.

What the INSULIN Act Proposes

The legislation, introduced by a bipartisan group of senators, aims to:

• Cap monthly insulin costs at $35 for privately insured patients

• Launch pilot programs in 10 states to support uninsured individuals

• Expand access to affordable insulin across different income groups

This proposal builds on earlier efforts. In 2022, insulin costs were capped at $35 per month for Medicare beneficiaries under the Inflation Reduction Act. However, that benefit does not extend to all Americans.

Why the Bill Matters

According to health data, over 8 million Americans rely on insulin, including more than 2 million people with Type 1 diabetes who depend on it for survival. Despite various state-level caps and manufacturer discount programs, many patients still face high out-of-pocket costs.

A key issue is that around 57% of privately insured Americans are enrolled in self-insured plans, which are not regulated by state laws. This leaves a large portion of patients without protection from existing cost caps.

Challenges Ahead

Although the bill has bipartisan backing, it faces significant hurdles in Congress. Previous attempts to pass similar legislation have failed due to political disagreements and procedural issues.

With Republicans currently controlling Congress and the White House, supporters see a potential opportunity for rare bipartisan agreement on healthcare affordability. However, competing legislative priorities could delay or derail progress.

Patient Impact and Hope

For many patients, even small savings can make a big difference. Young adults, in particular, often struggle with limited or no insurance coverage and high medical expenses.

Advocates believe that a nationwide $35 cap would not only reduce financial stress but also improve access to essential treatment. While uncertainty remains, patients and healthcare groups continue to push for reforms that make insulin more affordable.